K070463 is an FDA 510(k) clearance for the REVERA WOUND CARE, MODEL MDW0060. Classified as Dressing, Wound, Drug (product code FRO).
Submitted by Revalesio Corporation (Tacoma, US). The FDA issued a Cleared decision on May 7, 2008 after a review of 446 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.
View all Revalesio Corporation devices